Education
About Us
Working with TipRanks
Follow Us
Robert Gagnon Insider Profile
4 Followers
Robert Gagnon, Director at Harvard Bioscience, holds 110.00K shares in Harvard Bioscience (Ticker: HBIO), holds 42.24K shares in Verastem (Ticker: VSTM), holds ― shares in Bone Biologics (Ticker: BBLG).
Profitable Transactions
15 out of 25 Profitable Transactions
Average Return
-5.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Gagnon holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 30, 2017 - May 30, 2018
Return:+104.20%
The most profitable trade made by Robert Gagnon
Robert Gagnon's Trading History
Harvard Bioscience
Jul 18, 2025
Director
Uninformative Buy
―
$51.37K
Verastem
Jun 20, 2025
Director
Informative Sell
1.60K
$446.08K
Bone Biologics
―
Director
―
―
Biogen
Mar 01, 2012
VP Finance
Uninformative Sell
178.87K
$559.62K
Clean Harbors
Sep 12, 2012
EVP CFO and Treasurer
Uninformative Buy
―
$1.81M
List of latest transactions for each holding click on a transaction to see Robert Gagnon's performance on stock
You May Also Like
Robert Gagnon insider profile FAQ
What is the percentage of profitable transactions made by Robert Gagnon?
The percentage of profitable transactions made by Robert Gagnon is 60%.
What is the average return per transaction made by Robert Gagnon?
The average return per transaction made by Robert Gagnon is -5.30%.
What stocks does Robert Gagnon hold?
Robert Gagnon holds: HBIO, VSTM, BBLG, BIIB, CLH stocks.
What was Robert Gagnon’s latest transaction?
Robert Gagnon latest transaction was an Uninformative Buy of ―.
What was Robert Gagnon's most profitable transaction?
Robert Gagnon’s most profitable transaction was an Informative Buy of HBIO stock on May 30, 2017. The return on the trade was 104.20%.
What is Robert Gagnon's role in Harvard Bioscience?
Robert Gagnon's role in Harvard Bioscience is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.